Hironobu Hamada
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 67
- Occupational and environmental lung diseases 23
- Chronic Obstructive Pulmonary Disease (COPD) Research 23
- Lung Cancer Treatments and Mutations 22
- Inhalation and Respiratory Drug Delivery 12
- Medical Imaging and Pathology Studies 11
- Genetics top 1%
- Pharmacology top 0.5%
-
- Asthma and respiratory diseases 13
- Sarcoidosis and Beryllium Toxicity Research 12
- Co-authors
- Mark C. WillinghamF ThiébautMichael M. GottesmanT TsuruoI PastanNobuoki KohnoAkihito YokoyamaKunio Hiwada
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (2 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hironobu Hamada
213 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 3.3k
- Pulmonary and Respiratory Medicine 2.7k
- Genetics 676
- Pediatrics, Perinatology and Child Health 1.2k
- Pharmacology 472
Countries citing papers authored by Hironobu Hamada
This map shows the geographic impact of Hironobu Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hironobu Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hironobu Hamada more than expected).
Fields of papers citing papers by Hironobu Hamada
This network shows the impact of papers produced by Hironobu Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hironobu Hamada. The network helps show where Hironobu Hamada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hironobu Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 12 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 0 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 6 | |
| 17 | 2018 | 15 | |
| 18 | 2018 | 15 | |
| 19 | 2016 | 40 | |
| 20 | 2011 | 17 |
About Hironobu Hamada
Hironobu Hamada is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Clinical Biochemistry, having authored 229 papers that have together received 7.8k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (67 papers), Occupational and environmental lung diseases (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers), Lung Cancer Treatments and Mutations (22 papers), Asthma and respiratory diseases (13 papers), Sarcoidosis and Beryllium Toxicity Research (12 papers), Inhalation and Respiratory Drug Delivery (12 papers) and Medical Imaging and Pathology Studies (11 papers). The work is most often cited by research in Oncology (3.3k citations), Pulmonary and Respiratory Medicine (2.7k citations) and Genetics (676 citations). Hironobu Hamada has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Mark C. Willingham, F Thiébaut, Michael M. Gottesman, T Tsuruo, I Pastan, Nobuoki Kohno, Akihito Yokoyama, Kunio Hiwada, T Tsuruo and Noboru Hattori. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.